Peer-reviewedCC BY-NC-ND 4.0Nature Communications
Genome architecture drives antifungal resistance in Candida auris
Related
- Colonization by Candida spp. In oral mucosa lesions: a cross-sectional study on prevalence, risk factors, and antifungal resistance
- Nanoformulated silymarin enhances antifungal activity against resistant Candida albicans by reducing ergosterol and binding to cell envelope targets
- Antifungal activity of the nucleoside mimetic 5-fluorouridine against Candidozyma auris and Candida species
- Antimicrobial Peptoids Show Potent Antifungal Activity against Candidozyma (Candida) auris In Vivo and Broad-Spectrum Activity In Vitro against Other Candida Species.
- NT-A9, a new triazole, exhibits potent antifungal activity against Candida and Cryptococcus species through potent ergosterol biosynthesis inhibition
BibTeX
@article{chowdhary2026genome,
title = {{Genome architecture drives antifungal resistance in Candida auris}},
author = {Anuradha Chowdhary and Nityendra Shukla and Neeraj Chauhan},
journal = {Nature Communications},
year = {2026},
month = oct,
doi = {10.1038/s41467-026-78280-8},
url = {https://www.nature.com/articles/s41467-026-78280-8},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Genome architecture drives antifungal resistance in Candida auris
AU - Anuradha Chowdhary
AU - Nityendra Shukla
AU - Neeraj Chauhan
PY - 2026
DA - 2026/10/09
JO - Nature Communications
DO - 10.1038/s41467-026-78280-8
UR - https://www.nature.com/articles/s41467-026-78280-8
SN - 2041-1723
ER -